Effects of active components of Epimedium, Astragalus and Radix Puerariae on expression of hepcidin in hippocampus CA3 in APPswe/PSldE9 double transgenic Alzheimer's disease model mice
10.3969/j.issn.1001-1978.2019.11.009
- Author:
Dong-xue MA
1
Author Information
1. Dept of Pathophysiology, Chengde Medical College
- Publication Type:Journal Article
- Keywords:
Alzheimer's disease;
Astragalus;
Effective components of traditional Chinese medicine;
Epimedium;
Hepcidin;
Radix Puerariae;
Transgenic model
- From:
Chinese Pharmacological Bulletin
2019;35(11):1523-1527
- CountryChina
- Language:Chinese
-
Abstract:
Aim To explore the effect of a combination of Astragalus, Epimedium and Pueraria on the expression of hepcidin in hippocampal CA3 region of APPswe/PSldE9 double transgenic AD model mice. Methods Thirty 10-month-old APPswe/PSldE9 double transgenic model mice were randomly divided into three groups; the compound group, the model group and the deferox (D F X) group, and ten 10-month-old C57BL/6J mice were as normal control group. Subsequently, the brain tissue of the mice was taken out, and the expression of hepcidin in the hippocampal CA3 region of each group of mice was detected by immunofluorescence combined with Real-time PCR and Western blot. Results Compared withnormal group, the mRNA expression of hepcidin was down-regulated inmodel group. Afterintragastric administrationof active components of Epimedium, Astragalus and Radix Puerariae and DFX, hepcidin expression levels increased significantly compared with those in APPswe/PSldE9 double transgenic AD model mice hippocampal CA3 area (P < 0. 05). Compared with DFX group, there was no significant difference in mRNA expression and hepcidin protein indicesin compound group (P > 0. 05). Conclusions The effective components of Astragalus, Epimedium and Radix Puerariae can up-regulate the expression of hepcidin, It is suggested that the effective components of Epimedium, Astragalus, and Radix Puerariae have important theoretical significance in the clinical treatment of Alzheimer's disease with iron overload.
